BA vs MAZE · P/E 89, rev $89.46B vs $525.3M cap
The Boeing Company (BA) versus Maze Therapeutics, Inc. Common Stock (MAZE) — a side-by-side from cached financials, not a winner call.
The Boeing Company (BA) is a aerospace & defense company listed on NYSE. It is led by Kelly Ortberg.
Maze Therapeutics, Inc. Common Stock (MAZE) is a biotechnology company listed on US.
Latest reported BA revenue for 2025-12-31 was $89.46B. Net income was $2.23B. Revenue was up 34.5% from 2024-12-31 to 2025-12-31. BA currently screens at market cap $177.86B and trailing P/E 89.2.
Latest reported MAZE revenue for 2025-06-30 was $0. Net income was -$66.5M. Revenue was down 100.0% from 2024-09-30 to 2025-06-30. MAZE currently screens at market cap $525.3M.
BA currently screens at market cap $177.86B and trailing P/E 89.2. MAZE currently screens at market cap $525.3M.
Not investment advice. Open the BA and MAZE stock pages for the full models.
Not investment advice.